144 related articles for article (PubMed ID: 34792729)
1. Induction of estrogen receptor β-mediated autophagy sensitizes breast cancer cells to TAD1822-7, a novel biphenyl urea taspine derivative.
Su Q; Wu Q; Chen K; Wang J; Sarwar A; Zhang Y
Mol Biol Rep; 2022 Feb; 49(2):1223-1232. PubMed ID: 34792729
[TBL] [Abstract][Full Text] [Related]
2. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
3. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
[TBL] [Abstract][Full Text] [Related]
4. 17β-Estradiol and/or Estrogen Receptor β Attenuate the Autophagic and Apoptotic Effects Induced by Prolonged Hypoxia Through HIF-1α-Mediated BNIP3 and IGFBP-3 Signaling Blockage.
Hsieh DJ; Kuo WW; Lai YP; Shibu MA; Shen CY; Pai P; Yeh YL; Lin JY; Viswanadha VP; Huang CY
Cell Physiol Biochem; 2015; 36(1):274-84. PubMed ID: 25967966
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer.
Anestis A; Sarantis P; Theocharis S; Zoi I; Tryfonopoulos D; Korogiannos A; Koumarianou A; Xingi E; Thomaidou D; Kontos M; Papavassiliou AG; Karamouzis MV
J Cancer Res Clin Oncol; 2019 May; 145(5):1221-1233. PubMed ID: 30805773
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
Lindberg K; Helguero LA; Omoto Y; Gustafsson JÅ; Haldosén LA
Breast Cancer Res; 2011 Apr; 13(2):R43. PubMed ID: 21492444
[TBL] [Abstract][Full Text] [Related]
7. Eugenol-Induced Autophagy and Apoptosis in Breast Cancer Cells via PI3K/AKT/FOXO3a Pathway Inhibition.
Abdullah ML; Al-Shabanah O; Hassan ZK; Hafez MM
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502165
[TBL] [Abstract][Full Text] [Related]
8. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
Zhao X; Li X; Ren Q; Tian J; Chen J
Gene; 2016 Oct; 591(1):123-128. PubMed ID: 27393650
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
10. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
[TBL] [Abstract][Full Text] [Related]
11. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells.
Wang J; Liu X; Zheng H; Liu Q; Zhang H; Wang X; Shen T; Wang S; Ren D
Chem Biol Interact; 2020 Nov; 331():109279. PubMed ID: 33035517
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
Liu Y; Fan D
Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
[TBL] [Abstract][Full Text] [Related]
13. Calycosin induces apoptosis in osteosarcoma cell line via ERβ‑mediated PI3K/Akt signaling pathways.
Tian W; Wang ZW; Yuan BM; Bao YG
Mol Med Rep; 2020 Jun; 21(6):2349-2356. PubMed ID: 32236598
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
[TBL] [Abstract][Full Text] [Related]
15. Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy.
Ruddy SC; Lau R; Cabrita MA; McGregor C; McKay BC; Murphy LC; Wright JS; Durst T; Pratt MA
Mol Cancer Ther; 2014 Jul; 13(7):1882-93. PubMed ID: 24785256
[TBL] [Abstract][Full Text] [Related]
16. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways.
Machado VA; Peixoto D; Queiroz MJ; Soares R
J Cell Biochem; 2016 Dec; 117(12):2791-2799. PubMed ID: 27152982
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells.
Shi D; Zhao P; Cui L; Li H; Sun L; Niu J; Chen M
BMC Pharmacol Toxicol; 2020 May; 21(1):32. PubMed ID: 32357920
[TBL] [Abstract][Full Text] [Related]
19. TAD1822-7 induces ROS-mediated apoptosis of HER2 positive breast cancer by decreasing E-cadherin in an EphB4 dependent manner.
Zhu M; Tang X; Gong Z; Tang W; Zhang Y
Life Sci; 2021 Nov; 285():119954. PubMed ID: 34520770
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia.
Wang M; Wang Y; Weil B; Abarbanell A; Herrmann J; Tan J; Kelly M; Meldrum DR
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R972-8. PubMed ID: 19211725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
